Syndicated Research Studies

The global market for magnetoencephalography (MEG) was valued at USD 307.1 million in 2024, and is projected to grow to USD 569.7 million by 2033, representing a compound annual growth rate (CAGR) of 7.2% between 2025 and 2033. This expansion is primarily driven by ongoing improvements in MEG system technology, broader adoption of MEG in clinical and research settings, and a rising prevalence of neurological disorders globally, which cause significant death and disability. Advances in sensor precision, data-processing algorithms, and integration with other imaging modalities (such as MRI or PET) have greatly enhanced MEG's ability to measure and map brain activity with high spatial and temporal accuracy. These innovations make MEG more useful not only for diagnosing neurological conditions like epilepsy, stroke, and dementia, but also for studying brain function in cognitive science and neurodevelopment. Additionally, growing demand from both hospitals and research institutions h...

Magnetoencephalography Industry Overview The global magnetoencephalography market size was valued at USD 252.0 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.6% from 2021 to 2028. One of the primary reasons likely to drive the market over the forecast period is increasing technological improvements in magnetoencephalography (MEG) systems and their growing adoption. Also, the rising prevalence of neurological disorders causing death and disability worldwide is expected to fuel market growth. Furthermore, neurodegenerative diseases primarily affect people in their middle to late years of life, and their prevalence is predicted to rise as the population ages. According to Harvard Neurodiscovery Center, one in every five Americans will be over the age of 65 by 2030. If left untreated, more than 12 million Americans would suffer from neurodegenerative disorders in the next 30 years. Gather more insights about the market drivers, restrains and growt...